Tertius News is an AI-native newsroom: an AI model reads the linked source articles below and extracts what each outlet reported, so you can compare their coverage side by side. How this works →
Rays of Belief's IPO to open on Sep 1; price band set at ₹227-239/share
Rays of Belief Ltd, operating under the Mom's Belief brand, will launch its initial public offering on September 1 at a price band of ₹227-239 per share, with the issue closing on September 3. The company aims to raise ₹125 crore through a fresh issue of up to 52.30 lakh equity shares, with proceeds funding expansion of 319 new centres.
Rays of Belief Ltd, which operates under the Mom's Belief brand, is set to launch its initial public offering (IPO) on September 1, with a price band of ₹227-239 per share. The three-day public issue will close on September 3, while bidding by anchor investors will take place on August 31, according to the company's announcement on Monday.
The post-issue implied market capitalisation of the company is estimated at ₹474-500 crore, based on the price band. The IPO comprises a fresh issue of up to 52.30 lakh equity shares worth ₹125 crore at the upper end of the price band.
Mefcom Capital Markets is the book-running lead manager to the issue, while KFin Technologies is the registrar. The equity shares are proposed to be listed on the BSE and NSE on or about September 8.
Company profile and financial performance
Rays of Belief is a for-profit social enterprise providing personalised intervention plans for children with neurodevelopmental disorders (NDDs), including autism spectrum disorder, ADHD, Down Syndrome, cerebral palsy, intellectual disability, learning disabilities and global developmental delays. As of March 31, 2026, the company operated 136 centres across 57 cities in 20 states and union territories and had served more than 58,000 children since commencing operations in 2018.
The company's consolidated revenue from operations more than doubled to ₹81.66 crore in fiscal 2026 from ₹36.42 crore in the previous fiscal. Profit for the year stood at ₹4.96 crore in fiscal 2026, compared with ₹5.88 crore in the preceding fiscal.
Use of proceeds
The issue proceeds will be used to fund the company's expansion plans, including setting up 319 new centres between fiscal 2027 and fiscal 2029. Funds will also be allocated towards capital expenditure, including centre fit-outs, therapy-material inventory and technology hardware.
The IPO details were reported by the company, with coverage appearing in the Daily Excelsior, Free Press Journal, and The Hindu Business Line, which carried the same set of facts regarding the offer's structure, pricing, and financials.
How each outlet told it
Daily Excelsior
Framing: Headline emphasizes IPO opening date and price band; does not mention company's social enterprise nature or financial growth. — neutral/informative, supported by date and figures without evaluative language.
Facts Included:
IPO opens September 1
Price band Rs 227-239 per share
Post-issue implied market capitalisation estimated at Rs 474-500 crore
Three-day public issue closes September 3
Anchor investor bidding on August 31
Fresh issue of up to 52.30 lakh equity shares worth Rs 125 crore
Proceeds used for expansion, including 319 new centres between fiscal 2027 and fiscal 2029
Funds allocated for capital expenditure including centre fit-outs, therapy-material inventory, technology hardware
Company is a for-profit social enterprise for children with neurodevelopmental disorders (NDDs)
As of March 31, 2026, operated 136 centres across 57 cities in 20 states and union territories
Served more than 58,000 children since 2018
Consolidated revenue more than doubled to Rs 81.66 crore in fiscal 2026 from Rs 36.42 crore
Profit stood at Rs 4.96 crore in fiscal 2026 compared with Rs 5.88 crore in preceding fiscal
Equity shares proposed to be listed on BSE and NSE on or about September 8
Mefcom Capital Markets is book-running lead manager, KFin Technologies is registrar
Framing: Headline emphasizes IPO opening date and price band; does not mention company's social enterprise nature or financial growth. — neutral/informative, supported by date and figures without evaluative language.
Facts Included:
IPO opens September 1
Price band Rs 227-239 per share
Post-issue implied market capitalisation estimated at Rs 474-500 crore
Three-day public issue closes September 3
Anchor investor bidding on August 31
Fresh issue of up to 52.30 lakh equity shares worth Rs 125 crore
Proceeds used for expansion, including 319 new centres between fiscal 2027 and fiscal 2029
Funds allocated for capital expenditure including centre fit-outs, therapy-material inventory, technology hardware
Company is a for-profit social enterprise for children with neurodevelopmental disorders (NDDs)
As of March 31, 2026, operated 136 centres across 57 cities in 20 states and union territories
Served more than 58,000 children since 2018
Consolidated revenue more than doubled to Rs 81.66 crore in fiscal 2026 from Rs 36.42 crore
Profit stood at Rs 4.96 crore in fiscal 2026 compared with Rs 5.88 crore in preceding fiscal
Equity shares proposed to be listed on BSE and NSE on or about September 8
Mefcom Capital Markets is book-running lead manager, KFin Technologies is registrar
Framing: Headline emphasizes IPO opening date and price band; does not mention company's social enterprise nature or financial growth. — neutral/informative, supported by date and figures without evaluative language.
Facts Included:
IPO opens September 1
Price band ₹227-239 per share
Post-issue implied market capitalisation estimated at ₹474-500 crore
Three-day public issue closes September 3
Anchor investor bidding on August 31
Fresh issue of up to 52.30 lakh equity shares worth ₹125 crore
Proceeds used for expansion, including 319 new centres between fiscal 2027 and fiscal 2029
Funds allocated for capital expenditure including centre fit-outs, therapy-material inventory, technology hardware
Company is a for-profit social enterprise for children with neurodevelopmental disorders (NDDs)
As of March 31, 2026, operated 136 centres across 57 cities in 20 states and union territories
Served more than 58,000 children since 2018
Consolidated revenue more than doubled to ₹81.66 crore in fiscal 2026 from ₹36.42 crore
Profit stood at ₹4.96 crore in fiscal 2026 compared with ₹5.88 crore in preceding fiscal
Equity shares proposed to be listed on BSE and NSE on or about September 8
Mefcom Capital Markets is book-running lead manager, KFin Technologies is registrar
Each row is one claim, attributed to the outlet whose wording states it most clearly. Confidence rates how directly the source text states the claim — explicit and unhedged rates high; hedged, pieced-together, or internally inconsistent statements rate lower. It does not measure whether the claim is true. Status counts the distinct outlets we found asserting it — so a single-source claim can still show high confidence, and a multi-source claim can show medium. Every one of those outlets is named beside the status, so you can check the count against the list. For claims extracted before we began storing that list, the row says so: it names the outlet the claim is quoted from and states that we have not recorded which outlets backed it. Outlets wrote at different times, so a figure that evolves — a casualty count, for example — can legitimately differ between rows; check the "as of" time next to each claim's source.
Claim
Confidence
Status
ClaimRays of Belief Ltd, operating under the Mom's Belief brand, is set to launch its IPO on September 1.
ClaimRays of Belief is a for-profit social enterprise providing personalised intervention plans for children with neurodevelopmental disorders (NDDs), including autism spectrum disorder, ADHD, Down Syndrome, cerebral palsy, intellectual disability, learning disabilities and global developmental delays.